PE20160115A1 - Compuestos derivados de imidazol como inhibidores de protein quinasa - Google Patents
Compuestos derivados de imidazol como inhibidores de protein quinasaInfo
- Publication number
- PE20160115A1 PE20160115A1 PE2015002104A PE2015002104A PE20160115A1 PE 20160115 A1 PE20160115 A1 PE 20160115A1 PE 2015002104 A PE2015002104 A PE 2015002104A PE 2015002104 A PE2015002104 A PE 2015002104A PE 20160115 A1 PE20160115 A1 PE 20160115A1
- Authority
- PE
- Peru
- Prior art keywords
- protein kinase
- kinase inhibitors
- derived compounds
- pyrazol
- halogen
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 2
- RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 title 1
- 229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 title 1
- 239000003909 protein kinase inhibitor Substances 0.000 title 1
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- 125000006701 (C1-C7) alkyl group Chemical group 0.000 abstract 1
- UQPPINWNPFCKHL-UHFFFAOYSA-N 4-(2,4-difluorophenyl)-n-(1-methylpyrazol-3-yl)-6-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]pyridin-2-amine Chemical compound CN1C=CC(NC=2N=C(C=C(C=2)C=2C(=CC(F)=CC=2)F)N2C3=CC=C(C=C3N=C2)C2=CN(C)N=C2)=N1 UQPPINWNPFCKHL-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- OFQISPMWUCLRIV-UHFFFAOYSA-N n-[4-(2,4-difluorophenyl)-6-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]pyridin-2-yl]cyclopropanesulfonamide Chemical compound C1=NN(C)C=C1C1=CC=C(N(C=N2)C=3N=C(NS(=O)(=O)C4CC4)C=C(C=3)C=3C(=CC(F)=CC=3)F)C2=C1 OFQISPMWUCLRIV-UHFFFAOYSA-N 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se describe un compuesto de la formula (I), util en el tratamiento del cancer; donde Z1 es N; Z2 es CH o Z1 es CH y Z2 es N o Z1 y Z2 son N; Z es CH o N; A es anillo fenilo, etc. R1 es alquilo C1-C7, etc. R2 es H, halogeno, etc. B es anillo heterociclico, etc. R3 es H, halogeno, etc. R4 es H, halogeno, etc. R5 es H etc. Los compuestos preferidos son: 4-(2,4-difluorofenil)-N-(1-metil-1H-pirazol-3-il)-6-(5-(1-metil-1H-pirazol-4-il)-1H-benzo[d]imidazol-1-il)piridin-2-amina; N-(4-(2,4-difluorofenil)-6-(5-(1-metil-1H-pirazol-4-il)-1H-benzo[d]imidazol-1-il)piridin-2-il)ciclopropansulfonamida
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN382KO2013 | 2013-04-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20160115A1 true PE20160115A1 (es) | 2016-03-03 |
Family
ID=50685938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2015002104A PE20160115A1 (es) | 2013-04-04 | 2014-04-03 | Compuestos derivados de imidazol como inhibidores de protein quinasa |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US20160031855A1 (es) |
| EP (1) | EP2981533B1 (es) |
| JP (1) | JP6356782B2 (es) |
| KR (1) | KR20150138383A (es) |
| CN (1) | CN105073733B (es) |
| AR (1) | AR095781A1 (es) |
| AU (1) | AU2014246961B2 (es) |
| BR (1) | BR112015025413A2 (es) |
| CA (1) | CA2907855A1 (es) |
| CL (1) | CL2015002932A1 (es) |
| CY (1) | CY1120306T1 (es) |
| DK (1) | DK2981533T3 (es) |
| EA (1) | EA031076B1 (es) |
| ES (1) | ES2658183T3 (es) |
| HR (1) | HRP20180382T1 (es) |
| HU (1) | HUE036692T2 (es) |
| LT (1) | LT2981533T (es) |
| MA (1) | MA38454B1 (es) |
| MX (1) | MX2015013776A (es) |
| MY (1) | MY184528A (es) |
| NO (1) | NO2981533T3 (es) |
| NZ (1) | NZ713410A (es) |
| PE (1) | PE20160115A1 (es) |
| PH (1) | PH12015502284B1 (es) |
| PL (1) | PL2981533T3 (es) |
| PT (1) | PT2981533T (es) |
| RS (1) | RS56942B1 (es) |
| SA (1) | SA515361260B1 (es) |
| SG (1) | SG11201508125XA (es) |
| SI (1) | SI2981533T1 (es) |
| TW (1) | TWI628176B (es) |
| UA (1) | UA115176C2 (es) |
| WO (1) | WO2014162039A1 (es) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012088266A2 (en) | 2010-12-22 | 2012-06-28 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 |
| HUE042374T2 (hu) | 2012-06-13 | 2019-06-28 | Incyte Holdings Corp | Szubsztituált triciklusos vegyületek mint FGFR inhibitorok |
| US9388185B2 (en) | 2012-08-10 | 2016-07-12 | Incyte Holdings Corporation | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors |
| US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
| AR094812A1 (es) | 2013-02-20 | 2015-08-26 | Eisai R&D Man Co Ltd | Derivado de piridina monocíclico como inhibidor del fgfr |
| KR102469849B1 (ko) | 2013-04-19 | 2022-11-23 | 인사이트 홀딩스 코포레이션 | Fgfr 저해제로서 이환식 헤테로사이클 |
| KR102344105B1 (ko) | 2014-08-18 | 2021-12-29 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 모노시클릭 피리딘 유도체의 염 및 이의 결정 |
| US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
| AU2016219822B2 (en) | 2015-02-20 | 2020-07-09 | Incyte Holdings Corporation | Bicyclic heterocycles as FGFR inhibitors |
| WO2016134294A1 (en) | 2015-02-20 | 2016-08-25 | Incyte Corporation | Bicyclic heterocycles as fgfr4 inhibitors |
| CN114984013A (zh) | 2015-03-25 | 2022-09-02 | 国立癌症研究中心 | 胆管癌治疗剂 |
| WO2017104739A1 (ja) | 2015-12-17 | 2017-06-22 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 乳がん治療剤 |
| US10487863B2 (en) * | 2017-02-17 | 2019-11-26 | Ford Global Technologies, Llc | Castellated joint for improved adhesive coverage when using mechanical fixings and adhesive in one joint |
| UA125592C2 (uk) | 2017-03-16 | 2022-04-27 | Джянгсу Хенгруй Медісін Ко., Лтд. | ПОХІДНА ГЕТЕРОАРИЛ[4,3-c]ПІРИМІДИН-5-АМІНУ, СПОСІБ ЇЇ ОТРИМАННЯ ТА ЇЇ МЕДИЧНІ ЗАСТОСУВАННЯ |
| AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
| SG11202007591RA (en) | 2018-03-28 | 2020-09-29 | Eisai R&D Man Co Ltd | Therapeutic agent for hepatocellular carcinoma |
| EP4309737A3 (en) | 2018-05-04 | 2024-03-27 | Incyte Corporation | Solid forms of an fgfr inhibitor and processes for preparing the same |
| EP3788046B1 (en) | 2018-05-04 | 2025-12-10 | Incyte Corporation | Salts of an fgfr inhibitor |
| US11628162B2 (en) | 2019-03-08 | 2023-04-18 | Incyte Corporation | Methods of treating cancer with an FGFR inhibitor |
| AU2020242287A1 (en) | 2019-03-21 | 2021-09-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | A Dbait molecule in combination with kinase inhibitor for the treatment of cancer |
| WO2020249096A1 (zh) | 2019-06-14 | 2020-12-17 | 南京明德新药研发有限公司 | 作为fgfr和vegfr双重抑制剂的并环类化合物 |
| US11591329B2 (en) | 2019-07-09 | 2023-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| WO2021018047A1 (zh) | 2019-07-26 | 2021-02-04 | 南京明德新药研发有限公司 | 作为fgfr和vegfr双重抑制剂的吡啶衍生物 |
| US12122767B2 (en) | 2019-10-01 | 2024-10-22 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| WO2021076602A1 (en) | 2019-10-14 | 2021-04-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| WO2021076728A1 (en) | 2019-10-16 | 2021-04-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| KR20220098759A (ko) | 2019-11-08 | 2022-07-12 | 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) | 키나제 억제제에 대해 내성을 획득한 암의 치료 방법 |
| JP7720840B2 (ja) | 2019-12-04 | 2025-08-08 | インサイト・コーポレイション | Ｆｇｆｒ阻害剤としての三環式複素環 |
| KR20220131900A (ko) | 2019-12-04 | 2022-09-29 | 인사이트 코포레이션 | Fgfr 억제제의 유도체 |
| US12012409B2 (en) | 2020-01-15 | 2024-06-18 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
| EP4286382A4 (en) * | 2021-01-26 | 2025-01-08 | CGeneTech (Suzhou, China) Co., Ltd. | CRYSTAL FORM OF A METHYLPYRAZOLE-SUBSTITUTED PYRIDOIMIDAZOLE COMPOUND AND METHOD FOR PREPARING THE SAME |
| WO2022203399A1 (ko) * | 2021-03-26 | 2022-09-29 | 주식회사 스탠다임 | 아데노신 a2a 수용체 길항제 및 이의 용도 |
| CA3215903A1 (en) | 2021-04-12 | 2022-10-20 | Incyte Corporation | Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent |
| EP4352059A1 (en) | 2021-06-09 | 2024-04-17 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
| WO2022261159A1 (en) | 2021-06-09 | 2022-12-15 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003503354A (ja) * | 1999-06-30 | 2003-01-28 | メルク エンド カムパニー インコーポレーテッド | Ｓｒｃキナーゼ阻害剤化合物 |
| CA2376957A1 (en) * | 1999-06-30 | 2001-01-04 | Merck & Co., Inc. | Src kinase inhibitor compounds |
| US7521448B2 (en) * | 2003-08-21 | 2009-04-21 | Osi Pharmaceuticals, Inc. | N-substituted benzimidazolyl c-Kit inhibitors |
| CN101558068A (zh) * | 2006-10-16 | 2009-10-14 | 诺瓦提斯公司 | 用作蛋白激酶抑制剂的苯乙酰胺类 |
| CA2672213C (en) * | 2006-12-22 | 2016-02-16 | Astex Therapeutics Limited | Bicyclic amine derivatives as protein tyrosine kinase inhibitors |
| US8895745B2 (en) * | 2006-12-22 | 2014-11-25 | Astex Therapeutics Limited | Bicyclic heterocyclic compounds as FGFR inhibitors |
| GB0906472D0 (en) * | 2009-04-15 | 2009-05-20 | Astex Therapeutics Ltd | New compounds |
| CN102216300B (zh) * | 2009-09-30 | 2014-10-22 | 贝达药业股份有限公司 | 作为蛋白激酶抑制剂的化合物和组合物 |
| UA111382C2 (uk) * | 2011-10-10 | 2016-04-25 | Оріон Корпорейшн | Інгібітори протеїнкінази |
-
2014
- 2014-04-02 TW TW103112259A patent/TWI628176B/zh not_active IP Right Cessation
- 2014-04-03 WO PCT/FI2014/000003 patent/WO2014162039A1/en not_active Ceased
- 2014-04-03 EP EP14722686.4A patent/EP2981533B1/en active Active
- 2014-04-03 EA EA201591913A patent/EA031076B1/ru not_active IP Right Cessation
- 2014-04-03 UA UAA201510726A patent/UA115176C2/uk unknown
- 2014-04-03 HR HRP20180382TT patent/HRP20180382T1/hr unknown
- 2014-04-03 JP JP2016505869A patent/JP6356782B2/ja not_active Expired - Fee Related
- 2014-04-03 MA MA38454A patent/MA38454B1/fr unknown
- 2014-04-03 NO NO14722686A patent/NO2981533T3/no unknown
- 2014-04-03 ES ES14722686.4T patent/ES2658183T3/es active Active
- 2014-04-03 MY MYPI2015703505A patent/MY184528A/en unknown
- 2014-04-03 LT LTEP14722686.4T patent/LT2981533T/lt unknown
- 2014-04-03 CN CN201480019409.6A patent/CN105073733B/zh not_active Expired - Fee Related
- 2014-04-03 AU AU2014246961A patent/AU2014246961B2/en not_active Ceased
- 2014-04-03 SI SI201430589T patent/SI2981533T1/en unknown
- 2014-04-03 HU HUE14722686A patent/HUE036692T2/hu unknown
- 2014-04-03 RS RS20180257A patent/RS56942B1/sr unknown
- 2014-04-03 PT PT147226864T patent/PT2981533T/pt unknown
- 2014-04-03 PL PL14722686T patent/PL2981533T3/pl unknown
- 2014-04-03 MX MX2015013776A patent/MX2015013776A/es unknown
- 2014-04-03 BR BR112015025413A patent/BR112015025413A2/pt not_active Application Discontinuation
- 2014-04-03 KR KR1020157031629A patent/KR20150138383A/ko not_active Withdrawn
- 2014-04-03 US US14/782,020 patent/US20160031855A1/en not_active Abandoned
- 2014-04-03 CA CA2907855A patent/CA2907855A1/en not_active Abandoned
- 2014-04-03 PE PE2015002104A patent/PE20160115A1/es not_active Application Discontinuation
- 2014-04-03 NZ NZ713410A patent/NZ713410A/en not_active IP Right Cessation
- 2014-04-03 SG SG11201508125XA patent/SG11201508125XA/en unknown
- 2014-04-03 DK DK14722686.4T patent/DK2981533T3/en active
- 2014-04-04 AR ARP140101492A patent/AR095781A1/es unknown
-
2015
- 2015-10-01 PH PH12015502284A patent/PH12015502284B1/en unknown
- 2015-10-02 CL CL2015002932A patent/CL2015002932A1/es unknown
- 2015-10-04 SA SA515361260A patent/SA515361260B1/ar unknown
-
2018
- 2018-02-21 CY CY20181100204T patent/CY1120306T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20160115A1 (es) | Compuestos derivados de imidazol como inhibidores de protein quinasa | |
| PE20170677A1 (es) | Nuevos compuestos como inhibidores de reorganizado durante la transfeccion (ret) | |
| PE20161073A1 (es) | Amino-heteroaril-benzamidas como inhibidores de cinasa | |
| MX2017012613A (es) | Imidazolonilquinolinas y el uso de las mismas como inhibidores de cinasa atm. | |
| PE20210642A1 (es) | Inhibidores de pd-1/pd-l1 | |
| PE20170695A1 (es) | Compuestos de indol carboxamida utiles como inhibidores de cinasas | |
| PE20161066A1 (es) | Derivados de piperidinil-indol como inhibidores del factor de complemento b y usos de los mismos | |
| PE20141827A1 (es) | Inhibidores de proteinas quinasas | |
| PE20141855A1 (es) | Benzotienilo-pirrolotriazinas disustituidas y sus usos | |
| PE20231986A1 (es) | Compuesto de heteroarilcarboxamida | |
| SG10201806965XA (en) | 3-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancer | |
| PE20160524A1 (es) | Compuestos terapeuticamente activos y sus metodos de uso | |
| PE20140192A1 (es) | Derivados de bencimidazol como inhibidores de cinasa pi3 | |
| PE20170774A1 (es) | Compuestos de indazol como inhibidores de cinasa fgfr, preparacion y uso de los mismos | |
| PE20170664A1 (es) | Agonistas del receptor de apelina(apj) y usos de los mismos | |
| JO3025B1 (ar) | الأندازولات المستبدلة بالأوكسازول كمثبطات كيناز pi3 | |
| EA201200653A1 (ru) | Гетариламинохинолины | |
| PE20070517A1 (es) | Derivados de imidazol como agentes inhibidores de la sintasa de aldosterona y aromatasa | |
| EA201790715A1 (ru) | Новые соединения | |
| PE20141828A1 (es) | 6-alquinilo piridinas como mimeticos smac | |
| PE20171338A1 (es) | Compuestos y composiciones como inhibidores de quinasa raf | |
| PE20190805A1 (es) | Compuesto de piridina | |
| EA202091475A1 (ru) | ПРОИЗВОДНЫЕ 5-(2-(2,5-ДИФТОРФЕНИЛ)ПИРРОЛИДИН-1-ИЛ)-3-(1H-ПИРАЗОЛ-1-ИЛ)ПИРАЗОЛО[1,5-а]ПИРИМИДИНА И РОДСТВЕННЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ Trk КИНАЗЫ ДЛЯ ЛЕЧЕНИЯ РАКА | |
| MX2015015786A (es) | Compuestos de n-(tetrazol-5-il)- y n-(triazol-5-il) arilcarboxamida sustituidos y su uso como herbicidas. | |
| PE20160050A1 (es) | Inhibidores/ antiandrogenos novedosos de cyp17 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |